Difference between revisions of "Minutes - Medication WG 2021-03-30"

From Health Level 7 Belgium Wiki
Line 34: Line 34:
 
::* Medication Scheme : see [https://chat.fhir.org/#narrow/stream/179166-implementers/topic/Medication.20overview chat.fhir.org] with advice from Lloyd McKenzie
 
::* Medication Scheme : see [https://chat.fhir.org/#narrow/stream/179166-implementers/topic/Medication.20overview chat.fhir.org] with advice from Lloyd McKenzie
 
::* Definitions, see [https://build.fhir.org/ig/hl7-be/hl7-be-fhir-medication/branches/master/medicationrecord-definitions.html here]
 
::* Definitions, see [https://build.fhir.org/ig/hl7-be/hl7-be-fhir-medication/branches/master/medicationrecord-definitions.html here]
 
+
::* requirements, see [https://build.fhir.org/ig/hl7-be/hl7-be-fhir-medication/branches/master/medicationrecord-requirements.html here]
 +
::* treatment line should be next to summary, not under the summary, see [https://build.fhir.org/ig/hl7-be/hl7-be-fhir-medication/branches/master/toc.html here]
 +
::* Scenario 1 - concurrent medications, see [https://build.fhir.org/ig/hl7-be/hl7-be-fhir-medication/branches/master/medicationrecord-scenario-1.html here]: whatever we decide on grouping medications, there will be always another way to group them
 +
::* Scenario 2 - medication protocols, see [https://build.fhir.org/ig/hl7-be/hl7-be-fhir-medication/branches/master/medicationrecord-scenario-2.html here]
 +
::*
  
 
* Important that everyone understands in the same way what a therapy is, also for pharmacist and patient
 
* Important that everyone understands in the same way what a therapy is, also for pharmacist and patient

Revision as of 09:37, 30 March 2021

Attendees
  • Annemieke Vergauwe
  • Dieter Sauvillers
  • Elhassan Baazizi
  • Jan Lenie
  • Jean-Louis Maggetto
  • Jean-Michel Polfliet
  • Jens Penny
  • José Costa Teixeira
  • Karlien Erauw
  • Richard Francken
  • Robin Bosman
  • Tom De Backer
Excused/Not present
  • Anne Nerenhausen
  • Bruno Casneuf
  • Hanne Vuegen
  • Jeroen De Wilde
  • Lars Vanreppelen
  • Marc Buckens
  • Nils Devos
  • Tom Henkens
  • Pablo Christiaens
  • Will van Norel
Agenda
  • feedback on latest updates
Minutes
  • Medication Scheme : see chat.fhir.org with advice from Lloyd McKenzie
  • Definitions, see here
  • requirements, see here
  • treatment line should be next to summary, not under the summary, see here
  • Scenario 1 - concurrent medications, see here: whatever we decide on grouping medications, there will be always another way to group them
  • Scenario 2 - medication protocols, see here
  • Important that everyone understands in the same way what a therapy is, also for pharmacist and patient
  • All this will have an impact on dispensation
  • José thinks of putting definitions together of a treatment line, snapshots etc
  • Capture important points that we cannot forget in a google doc
  • people can send their remarks in the chat and Karlien will collect them
  • for example:
  • When do we need to create or update a treatment line
  • Do we need "days left" in treatment ?
  • Received feedback on implementation guide
  • start and end date, why not use period datatype : logical model does go into that detail yet
  • FHIR datatypes are not referenced at logical datamodel level
  • there are 2 types of identifier on treatment line
  • treatment line has a unique identifier and has to have the medication parent an can have 1-many treatments (f.e. paracatemol can be there for a flu treatment and a headache treatment)
  • it should be a reference, not a unique identifier - will be corrected

* Action items

  • setup timeline: by when publishing a minimum viable model for the medication scheme (in the upcoming weeks TBC) - José
  • prepare definitions of treatment line, snapshots etc - José
  • any questions or important points to take into account in the future: put them in the chat - all


Next meeting April 13 at 11AM